ARYA Sciences III (ARYB), announced the pricing of their upsized $130 million IPO tonight and the units are expected to begin trading tomorrow, Friday, August 7, under the symbol Nasdaq: ARYB.

The company intends to focus its target search on the life sciences and medical technology sectors and will be led by Adam Stone as CEO and Director.  Stone will be joined by Michael Altman as as CFO and director as well as Joseph Edelman, serving as chairman of the Board.

Total SPAC deal count for 2020 year-to-date is now 63 with $25.4 billion in gross proceeds raised. The offering is anticipated to close on Friday, August 7, 2020.

Jefferies and Goldman Sachs are acting as the book running managers for the offering. Kirkland & Ellis serve as Issuer’s Counsel with Skadden, Arps, Slate, Meagher & Flom serving as Underwriter’s Counsel. WithumSmith+Brown, PC, serves as auditor.